Elicio Therapeutics (ELTX) Non Operating Income (2020 - 2026)
Elicio Therapeutics (ELTX) reported Non Operating Income of -$1.2 million for Q1 2026, down 158.14% on a YoY basis from $2.1 million in Q1 2025, and down 208.63% quarter-over-quarter from $1.1 million in Q4 2025.
Elicio Therapeutics (ELTX) Non Operating Income (2020 - 2026) Analysis & Trends
Elicio Therapeutics has reported Non Operating Income for 7 years, with the latest figure at -$1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 158.14% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$2.6 million (up 55.09% YoY), and the FY2025 full-year result was -$1.9 million, up 73.13% from the prior year.
- Non Operating Income for Q1 2026 stood at -$1.2 million, down from $1.1 million in the prior quarter.
- The five-year high for Non Operating Income was $3.7 million in Q2 2024, with the low at -$8.5 million in Q3 2024.
- Historically, Non Operating Income has averaged -$728294.1 across 5 years, with a median of -$473000.0 in 2025.
- The largest YoY upside for Non Operating Income was 1594.95% in 2024 against a maximum downside of 7616.81% in 2024.
- Elicio Therapeutics' Non Operating Income stood at -$690000.0 in 2022, then surged by 164.2% to $443000.0 in 2023, then sank by 219.19% to -$528000.0 in 2024, then soared by 312.88% to $1.1 million in 2025, then tumbled by 208.63% to -$1.2 million in 2026.
- The last three Non Operating Income figures came in at -$1.2 million (Q1 2026), $1.1 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | -2.04 Mn |
| Jun 30, 2025 | -470,000.00 |
| Mar 31, 2025 | -473,000.00 |
| Dec 31, 2024 | -528,000.00 |
| Sep 30, 2024 | -8.49 Mn |
| Jun 30, 2024 | 3.70 Mn |
| Mar 31, 2024 | -1.59 Mn |
| Dec 31, 2023 | 443,000.00 |
| Sep 30, 2023 | 113,000.00 |
| Jun 30, 2023 | 218,000.00 |
| Mar 31, 2023 | -224,000.00 |
| Dec 31, 2022 | -690,000.00 |
| Sep 30, 2022 | -1.43 Mn |
| Jun 30, 2022 | -1.07 Mn |
| Mar 31, 2022 | 245,000.00 |
| Dec 31, 2021 | 256,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 1.17 Mn |